ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6531
-0.21%
Brent Oil
82.885
1.10%
Bitcoin
70,373.18
2.72%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Human Genome Sciences, Inc. (MM) (HGSI)

  7. Human Genome Sciences, Inc. (MM) (HGSI) Noticias

HGSI

Human Genome Sciences (HGSI)

Human Genome Sciences, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HGSI
FechaHoraFuenteTítuloSímboloCompañía
03/08/201208:47Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
03/08/201207:52Edgar (US Regulatory)(25-NSE)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
03/08/201202:00Dow Jones NewsGlaxoSmithKline Completes Acquisition of Human Genome SciencesNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201216:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201216:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201213:24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201211:55ZacksLoss at HGSI Wider Than Expected - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
31/07/201214:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
30/07/201208:06Dow Jones NewsGlaxoSmithKline Gets 79% Tenders for Human Genome Sciences OfferNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201215:22Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201214:49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201210:46PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201204:45ZacksGlaxo Misses, Guidance Lowered - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
20/07/201208:32Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
19/07/201218:36Business WireLaw Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breache...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
19/07/201212:44ZacksGlaxo to Increase Stake in Amicus - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201220:00PR Newswire (US)Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201216:10Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201214:05Business WireRyan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201214:05Business WireHuman Genome Sciences Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow &...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201213:10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201211:22Business WireRobbins Umeda LLP Announces an Investigation of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201211:16MarketwiredTraders: Most Active Stocks: (OTCBB: CTDT), (NASDAQ: HGSI), (NASDAQ: AAPL), (NASDAQ: MAT)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201211:12Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201211:12ZacksHGSI Accepts Glaxo's $14.25 Bid - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201209:53Business WireHuman Genome Sciences Shareholder Alert: The Briscoe Law Firm & Powers Taylor, LLP Investigate Sale of Human Genome Sciences ...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201216:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201211:18Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Human ...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201208:15Business WireGSK to acquire Human Genome Sciences for US$14.25 per share in cashNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
15/07/201218:10Dow Jones NewsGlaxo Eyes Human Genome Sciences for $2.6 BillionNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:HGSI

Su Consulta Reciente

AMEX
XLE
Energy Select Sector SPDR
FX
USDMXN
US Dollar vs MXN
NYSE
NKE
Nike
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
CCOM
US30
US 30
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
CCOM
OILBRENT
Brent Oil
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
NASDAQ
GOOGL
Alphabet
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados